OJOG  Vol.5 No.5 , May 2015
Uptake of Hormonal Implants Contraceptive in Zaria, Northern Nigeria
ABSTRACT

Objective: To document our experience on the use of Jadelle/Implanon contraceptives that was recently introduced into Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria. It is pertinent to generate data on the experiences in the use of this contraceptive in a cross sectional study within Zaria, Northern Nigeria. Method: Data on consecutive clients that accepted Jadelle/ Implanon from June 2009 to November 2013 at ABUTH were extracted from their cards and analyzed using SPSS version 17. Out of a total of 11,502 clients that were for contraception during the period under review, 798 accepted Jadelle/Implanon accounting for 7% of the total clients. All the clients were married. About 67.8% were Muslims while 27.2% were Christians and 5% belong to other sect. 4140 (36%) had tertiary education. Most of the client has been on one form of modern contraception; only 16% were first time users who accepted implant after counselling. 37% of the clients are full time housewives. The discontinuation rate was found to be 26% for Jadelle and 19% for Implanon. No pregnancy was recorded during this period. Conclusion: Jadelle/Implanon account for 7% of contractive uptake and a high discontinuation rate was found among the users.


Cite this paper
Madugu, N. , Abdul, M. , Bawa, U. and Kolawole, B. (2015) Uptake of Hormonal Implants Contraceptive in Zaria, Northern Nigeria. Open Journal of Obstetrics and Gynecology, 5, 268-273. doi: 10.4236/ojog.2015.55039.
References
[1]   National Population Commission, NDHS (2008) National Population Commission. ORC Marco, Calverton.

[2]   Engender Health (2011) SEED Assessment Guide for Family Planning Programming. Engender Health, New York.
http://www.engenderhealth.org/pubs/family-planning/seed-assessment-guide-for-family-planning.php

[3]   Hubacher, D., Olawo, A., Manduku, C. and Kiarie, J. (2011) Factors Associated with Uptake of Subdermal Contraceptive Implants in a Young Kenyan Population. Contraception, 84, 413-417.
http://dx.doi.org/10.1016/j.contraception.2011.02.007

[4]   Ladipo, O.A. and Akinso, S.A. (2005) Contraceptive Implants. African Journal of Reproductive Health, 9, 16-30.
http://dx.doi.org/10.2307/3583156

[5]   Ali, M.M., Cleland, J. and Shah, I.H. (2012) Causes and Consequences of Contraceptive Discontinuation: Evidence from 60 Demographic and Health Surveys. World Health Organization, Geneva.

[6]   Darney, P.D. (1994) Hormonal Implants: Contraception for a New Century. America Journal of Obstetrics and Gynecology, 170, 1536.
http://dx.doi.org/10.1016/s0002-9378(94)05016-7

[7]   (1993) Bangladesh Institute of Research for Promotion of Essential & Reproductive Health and Technologies, Dhaka, 47, 569-582.

[8]   Jacobstein, R. (2009) Fostering Change in Medical Settings: Some Considerations for Family Planning Programmes. IPPF Medical Bulletin, 43, 3-4.

[9]   Wickstrom, J. and Jacobstein, R. (2011) Contraceptive Security: Incomplete without Long-Acting and Permanent Methods of Family Planning. Studies in Family Planning, 42, 291-298.
http://dx.doi.org/10.1111/j.1728-4465.2011.00292.x

[10]   Murthil, J.H. and Nyango, D.D. (2010) East African Medical Journal, 89, 461-464.

[11]  
http://www.drugs.com/pro/implanon.html

[12]   Hubacher, D., Mavranezouli, I. and McGinn, E. (2008) Unintended Pregnancy in Sub-Saharan Africa: Magnitude of the Problem and Potential Role of Contraceptive Implants to Alleviate it. Contraception, 78, 73-78.

[13]   Akhter, H., Dunson, T.R., Amatya, R.N., Begum, K., Chowdhury, T., Dighe, N., Krueger, S.L. and Rahman, S. (1993) A Five-Year Clinical Evaluation of Norplant Contraceptive Subdermal Implants in Bangladeshi Acceptors. Contraception, 47, 569-582.

[14]   Peralta, O., Diaz, A. and Crozatto (1995) Journal of Steriod Biochemical Molecular Biology, 53.

[15]   Chigbu, B., Onwere, S., Aluka, C., Kamanu, C., Okoro, O. and Feyi-Waboso, P. (2010) Contraceptive Choices of Women in Rural Southeastern Nigeria. Nigerian Journal of Clinical Practice, 13, 195-199.

 
 
Top